Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Peetz Christopher (CIK 1614740) reported 34 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-03). Recent activity: Buy MIRM (30,000 shares), Sell MIRM (8,312 shares), Sell MIRM (21,688 shares), Buy MIRM (20,000 shares), Sell MIRM (11,683 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 30,000 | $88,080 |
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 8,312 | $815,241 |
| 2026-09-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 21,688 | $2.1M |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 20,000 | $58,720 |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 11,683 | $1.2M |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 6,017 | $597,187 |
| 2026-08-11 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 2,300 | $230,322 |
| 2026-07-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 4,315 | $0 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 1,710 | $213,391 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 12,134 | $1.5M |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 4,181 | $511,504 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 1,975 | $244,386 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 20,000 | $58,720 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 30,000 | $88,200 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 2,602 | $246,253 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 16,595 | $1.6M |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 6,926 | $665,935 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 1,973 | $192,486 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 1,021 | $100,262 |
| 2026-06-02 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 883 | $88,000 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 25,000 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 50,000 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 40,985 | $3.8M |
| 2026-02-03 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Sell | 9,108 | $940,856 |
| 2026-01-27 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF EXECUTIVE OFFICER | Buy | 12,500 | $0 |
Source: SEC Form 4 filings · as of 2026-09-03